Juan Ángel Aibar-Durán, Gloria Villalba Martínez, Berta Freixer-Palau, Elena Araus-Galdós, Noemi Morollón Sanchez-Mateos, Robert Belvis Nieto, Miren Revuelta Rizo, Joan Molet Teixeido, Carmen García Sánchez, Cristian de Quintana Schmidt, Fernando Muñoz Hernandez, Rodrigo Rodríguez Rodríguez
BACKGROUND AND OBJECTIVES: Cortical motor stimulation (CMS) is used to modulate neuropathic pain. The literature supports its use; however, short follow-up studies might overestimate its real effect. This study brings real-world evidence from two independent centers about CMS methodology and its long-term outcomes. METHODS: Patients with chronic refractory neuropathic pain were implanted with CMS. The International Classification of Headache Disorders 3rd Edition was used to classify craniofacial pain and the Douleur Neuropathique en 4 Questions Scale score to explore its neuropathic nature...
August 28, 2023: Neurosurgery